Custom Menopause Hormones Have Unpredictable Ingredient Mix Custom Menopause Hormones Have Unpredictable Ingredient Mix
Women who fill prescriptions for compounded, custom-blended hormone therapy may get capsules or creams that don't contain the correct amount of medicine, a recent study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 9, 2019 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Study confirms disparities in triple-negative breast cancer diagnoses
(Wiley) A new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society, shows that women of color and young women may face elevated risks of developing triple-negative breast cancers, which are often aggressive and do not respond to hormone therapy or targeted therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 8, 2019 Category: International Medicine & Public Health Source Type: news

Hormone therapy for prostate cancer may raise risk of Alzheimer's, Dementia
(University of Pennsylvania School of Medicine) A Penn study of more than 150,000 men with prostate cancer shows androgen deprivation therapy was associated with a higher likelihood of developing dementia when compared to patients who were not exposed to the treatment. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 8, 2019 Category: International Medicine & Public Health Source Type: news

Custom menopause hormones have unpredictable ingredient mix
(Reuters Health) - Women who fill prescriptions for custom-blended hormone therapy may get capsules or creams that don't contain the correct amount of medicine, a recent study suggests. (Source: Reuters: Health)
Source: Reuters: Health - July 5, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Utility of Biochemical Screening for Pituitary Deficiencies Utility of Biochemical Screening for Pituitary Deficiencies
Biochemical screening is routinely used to identify pituitary hormone deficiencies and adverse effects of growth hormone therapy, but is it really necessary?Journal of the Endocrine Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 5, 2019 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news

Hormone Therapy for Prostate Cancer Tied to Dementia
Androgen deprivation therapy for prostate cancer is associated with an increased risk of Alzheimer ’s disease and other forms of dementia. (Source: NYT Health)
Source: NYT Health - July 3, 2019 Category: Consumer Health News Authors: Nicholas Bakalar Tags: Alzheimer ' s Disease Prostate Cancer Dementia Hormones Source Type: news

Bone Mass Effects of Hormone Therapy in Transgender People Bone Mass Effects of Hormone Therapy in Transgender People
In what ways might long-term cross-sex hormone therapy impact bone mineral density among transgender men and women?Journal of the Endocrine Society (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - June 28, 2019 Category: Intensive Care Tags: Rheumatology Journal Article Source Type: news

Lack of transgender guidelines for older adults
There is a lack of knowledge and research on hormone therapy in adults aged 50 or over, although the risks of transgender treatment are likely to change with advancing age, according to a paper published inMaturitas.Medscape (Source: Society for Endocrinology)
Source: Society for Endocrinology - June 24, 2019 Category: Endocrinology Source Type: news

Low Lean Mass in Patients With Adult GH Deficiency Low Lean Mass in Patients With Adult GH Deficiency
How did the prevalence of low lean mass differ between patients who received growth hormone therapy and those who did not?Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 19, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

AHA News: Are Transgender Men and Women Who Take Hormones at Risk for Heart Disease?
FRIDAY, June 14, 2019 (American Heart Association News) -- The impact of hormone therapy on the heart health of transgender men and women has been the subject of several studies published within the last year. But medical experts and researchers... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 14, 2019 Category: General Medicine Source Type: news

Living With Cancer: Hormone therapy for prostate cancer
Hormone therapy for prostate cancer Most prostate cancer cells rely on testosterone to help them grow. Hormone therapy for prostate cancer, also called androgen deprivation therapy, is a treatment to stop the male hormone testosterone from reaching prostate cancer cells in your body. Learn about how the therapy works, the possible side effects and risks, [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 14, 2019 Category: Databases & Libraries Source Type: news

Dr. Debu Tripathy on Ribociclib Plus Hormone Therapy for Breast Cancer Patients
Cancer Network spoke with Debu Tripathy, MD, Chair of Breast Medical Oncology at MD Anderson Cancer Center, on how ribociclib plus hormone therapy extends survival for patients with premenopausal advanced HR-positive breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - June 10, 2019 Category: Cancer & Oncology Authors: Debu Tripathy, MD Source Type: news

Free Online Tool Predicts Late ER+ Breast Cancer Recurrence Free Online Tool Predicts Late ER+ Breast Cancer Recurrence
Clinical calculator could spare breast cancer patients 5 years of unnecessary hormone therapy.Medscape News UK (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 5, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Medical News Today: Menopause and heart health: Why timing hormone therapy is key
Researchers at the University of Guelph in Canada are the first to study how perimenopause affects heart health in female mice. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 3, 2019 Category: Consumer Health News Tags: Menopause Source Type: news

Adding targeted therapy to treatment extends lives of those with metastatic breast cancer
(MediaSource) A UCLA-led study has found that using a drug called ribociclib in combination with a common hormone therapy may help premenopausal women with the most common type of breast cancer live longer than if they only receive the hormone therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 3, 2019 Category: International Medicine & Public Health Source Type: news

New breast cancer treatment offers hope of longer life to younger women
Combining ribociclib with hormone therapy found to cut risk of death by up to a thirdYounger women with breast cancer have been given the hope of living longer after what is described as “one of the greatest advances in breast cancer research in recent decades”.Adding ribociclib, a targeted drug that disrupts cancer cells, to standard hormone therapy was found to boost survival among premenopausal patients who have an advanced form of the disease.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - June 1, 2019 Category: Science Authors: Jamie Doward Tags: Breast cancer Medical research Drugs Health Society NHS Science UK news World news Source Type: news

Adding ribociclib to hormone therapy extends lives of women with most common breast cancer
A UCLA-led study has found that using a drug called ribociclib in combination with a common hormone therapy may help premenopausal women with the most common type of breast cancer live longer than if they only receive the hormone therapy.Ribociclib is considered a cyclin-dependent kinase inhibitor that works by blocking the activity of proteins called cyclin-dependent kinase 4/6 enzymes, which promote cell division and cancer growth.The study involved 672 women aged 25 to 59 when the study began who had advanced hormone-receptor positive/HER2- breast cancer. Seventy percent of the women who took the combination therapy wer...
Source: UCLA Newsroom: Health Sciences - June 1, 2019 Category: Universities & Medical Training Source Type: news

Newer Drug Kisqali (ribociclib) Extends Lives of Young Breast Cancer Patients
SATURDAY, June 1, 2019 -- Adding a newer drug to standard hormone therapy lengthens the lives of younger women with advanced breast cancer, a new trial has found. The drug, called Kisqali (ribociclib), is already approved for treating such patients... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 1, 2019 Category: General Medicine Source Type: news

Newer Drug Extends Lives of Young Breast Cancer Patients
SATURDAY, June 1, 2019 -- Adding a newer drug to standard hormone therapy lengthens the lives of younger women with advanced breast cancer, a new trial has found. The drug, called Kisqali (ribociclib), is already approved for treating such patients... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 1, 2019 Category: General Medicine Source Type: news

Ribociclib plus hormone therapy extends survival for patients with premenopausal advanced hormone receptor-positive breast cancer
(University of Texas M. D. Anderson Cancer Center) Adding the targeted therapy ribociclib to hormone therapy significantly improved overall survival (OS) in premenopausal patients with advanced hormone receptor-positive (HR+) breast cancer, according to results of the MONALEESA-7 Phase III clinical trial led by researchers at The University of Texas MD Anderson Cancer Center. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 1, 2019 Category: Cancer & Oncology Source Type: news

First-Line Cabazitaxel Proves Beneficial in Patients With Metastatic Prostate Cancer
This study tested first-line treatment with cabazitaxel vs hormonal therapy in patients with metastatic castration-resistant prostate cancer with poor prognosis. (Source: CancerNetwork)
Source: CancerNetwork - June 1, 2019 Category: Cancer & Oncology Authors: Lauren M. Dembeck Source Type: news

Clinical calculator could spare breast cancer patients five years of unnecessary hormone therapy
(The Royal Marsden NHS Foundation Trust) New research confirms that an algorithm, called CTS5, can accurately identify patients who are at a significantly low risk of their breast cancer returning at a later stage. In doing so it means some patients may need to take hormone therapy for five years, rather than 10, something that researchers say could have a huge impact both psychologically and physically. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 30, 2019 Category: Cancer & Oncology Source Type: news

Cognitive behavior therapy shown to improve multiple menopause symptoms
(The North American Menopause Society (NAMS)) Although hormone therapy (HT) is the most commonly recommended treatment for menopause symptoms, research is ongoing for alternatives, especially nonpharmacologic options. Cognitive behavior therapy has previously been proposed as a low-risk treatment for hot flashes, but a new study suggests it may also effectively manage other menopause symptoms. Results are published online today in Menopause, the journal of The North American Menopause Society (NAMS). (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 29, 2019 Category: International Medicine & Public Health Source Type: news

Novartis' breast cancer treatment wins FDA approval
The U.S. Food and Drug Administration (FDA) said on Friday that it had approved Novartis AG's treatment in combination with a hormone therapy for postmenopausal women, as well as for men, with a form of advanced breast cancer. (Source: Reuters: Health)
Source: Reuters: Health - May 24, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Hormone Therapy in Transgender Women Ups Breast Cancer Risk
Transgender people on hormones, cisgender people should follow same breast cancer screening guidelines (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 20, 2019 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Internal Medicine, Oncology, Pharmacy, Journal, Source Type: news

Hormone Therapy in Transgender Women Ups Breast Cancer Risk
MONDAY, May 20, 2019 -- Transgender women receiving hormone treatments are at greater risk for developing breast cancer than cisgender men, according to a study published online May 15 in The BMJ. Christel J.M. de Blok, Ph.D., of the VU University... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 20, 2019 Category: Pharmaceuticals Source Type: news

Transwomen receiving hormone therapy are more likely to develop breast cancer
A study published in theBMJhas suggested that transgender women are at a greater risk of developing breast cancer after hormone replacement therapy.Daily Mail (Source: Society for Endocrinology)
Source: Society for Endocrinology - May 16, 2019 Category: Endocrinology Source Type: news

A Low-Fat Diet May Lower the Risk of Dying from Breast Cancer
In this study, volunteers were provided with dietary guidelines to follow about what to eat. “Until this study, we lacked any data from a prospective randomized control trial, which is the gold standard, for showing that a dietary approach really does reduce the risk of dying from breast cancer,” says Dr. Neil Iyengar, a medical oncologist at Memorial Sloan Kettering Cancer Center, who was not involved in the study. “Many of us who are proponents of considering diet and exercise in the cancer treatment plan are excited by this trial data because it is the first to show in a very robust way that we can imp...
Source: TIME: Health - May 15, 2019 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer embargoed study Source Type: news

Trans Women on Hormones Have More Breast Cancer
Researchers found that trans women on hormone therapy had a higher breast cancer risk than the general male population but lower than the general female population. (Source: WebMD Health)
Source: WebMD Health - May 15, 2019 Category: Consumer Health News Source Type: news

Trans Women Have Raised Odds of Breast Cancer, But Risk Still Small: Study
WEDNESDAY, May 15, 2019 -- Transgender women on gender-confirming hormone therapy have increased odds of breast cancer, but the overall risk is low and not as high as it is for the general female population, a new study finds. Trans women are those... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 15, 2019 Category: General Medicine Source Type: news

Transgender Females Have Lower Tenofovir Diphosphate Concentrations Transgender Females Have Lower Tenofovir Diphosphate Concentrations
Transgender females taking feminizing hormone therapy (FHT) have lower effective rectal tissue concentrations of tenofovir diphosphate active metabolites, compared with cisgender women and men, researchers report.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - May 13, 2019 Category: Infectious Diseases Tags: Diabetes & Endocrinology News Source Type: news

Hormone therapy may reduce the risk of miscarriage
A study published inThe New England Journal of Medicine has found that treating some women with progesterone during pregnancy can reduce the risk of miscarrying.BBC (Source: Society for Endocrinology)
Source: Society for Endocrinology - May 9, 2019 Category: Endocrinology Source Type: news

Link between hormone therapy and dementia risk proposed
Men undergoing hormone therapy to treat prostate cancer may be at a higher risk of developing dementia, according to research due to be presented at the American Urological Association annual meeting.Medical Xpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - May 7, 2019 Category: Endocrinology Source Type: news

Does Hormone Therapy for Prostate Cancer Raise Dementia Risk?
Title: Does Hormone Therapy for Prostate Cancer Raise Dementia Risk?Category: Health NewsCreated: 5/5/2019 12:00:00 AMLast Editorial Review: 5/6/2019 12:00:00 AM (Source: MedicineNet Alzheimer)
Source: MedicineNet Alzheimer - May 6, 2019 Category: Geriatrics Source Type: news

Does Hormone Therapy for Prostate Cancer Raise Dementia Risk?
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - May 6, 2019 Category: Cancer & Oncology Source Type: news

Does Hormone Therapy for Prostate Cancer Raise Dementia Risk?
SUNDAY, May 5, 2019 -- When men with prostate cancer have to take drugs that block the testosterone fueling their tumors, they can suffer a host of side effects that include impotence, bone loss, heart trouble and obesity. But new research uncovers... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 5, 2019 Category: General Medicine Source Type: news

Growth hormone treatment may help children with rare disorder
According to data, presented at thePediatric Endocrine Society annual meeting, growth hormone therapy improved growth in children suffering from aggrecan deficiency after six months of treatment.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - May 3, 2019 Category: Endocrinology Source Type: news

A new method to select the right treatment for advanced prostate cancer
(Karolinska Institutet) Researchers at Karolinska Institutet in Sweden have identified blood-based biomarkers that may determine which patients will benefit from continued hormonal therapy for advanced prostate cancer. The results are published in the journal JAMA Oncology. The researchers envision that this discovery may eventually result in a test that contributes to a more personalised treatment of the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 2, 2019 Category: Cancer & Oncology Source Type: news

Ghana: A Look At Castration-Resistant Prostate Cancer
[Ghanaian Times] There feedbacks to the piece on prostate cancer (PrCa) screening. I would like to share this particular feedback. I was diagnosed with prostate cancer a few years ago. I opted for hormonal therapy which comprised of three monthly injection with Goserelin injection. Recently I was informed that the prostate cancer was castration resistant and therefore has to be on another regime. I was aghast when I learnt that my prostate cancer was castration resistant. Throughout my therapy with Goserelin injection, I d (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 30, 2019 Category: African Health Source Type: news

Study Supports Radiation for Early, Hormone-Driven Breast Cancer
FRIDAY, April 26, 2019 -- For women with hormone-driven breast cancer, adding radiation to hormone therapy might keep their cancer from coming back for up to a decade, a new study finds. Breast cancer didn't come back in the same breast for 97.5%... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 26, 2019 Category: General Medicine Source Type: news

Some patients with imminently fatal cancer still receive treatment
(American Cancer Society) Patients who died within one month of being newly diagnosed with metastatic cancer in the United States received ineffective surgery, chemotherapy, radiation, and hormonal therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 15, 2019 Category: Cancer & Oncology Source Type: news

NICE rules against new hormone therapy combo for breast cancer
Draft guidance on ribociclib with fluvestrant under consultation Related items fromOnMedica NICE rejects adjuvant use of breast cancer drug Breast cancer deaths down due to screening and new therapies New breast cancer drug ‘unaffordable’ for NHS Red tape delaying availability of new cancer drugs One in 10 children in phase I cancer trials respond to drugs (Source: OnMedica Latest News)
Source: OnMedica Latest News - April 10, 2019 Category: UK Health Source Type: news

Estrogen and Cognition: An Enigma in Postmenopausal Women Estrogen and Cognition: An Enigma in Postmenopausal Women
Does hormone therapy improve cognition in women after menopause? Dr JoAnn Manson highlights the latest data and what it means for clinical practice.Medscape Ob/Gyn (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 5, 2019 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news

Estrogen therapy boosts transgender women's brains
A new study from collaborating researchers in Brazil and Canada found that when trans women were on hormone therapy, they had better connections between important brain regions. (Source: the Mail online | Health)
Source: the Mail online | Health - March 26, 2019 Category: Consumer Health News Source Type: news

Endometriosis Awareness Month
March is Endometriosis Awareness Month.  Endometriosis is a painful condition where endometrial tissue grows outside the uterus. It is estimated that up to 10% of women have endometriosis (Ozkan 2008).   Endometriosis can cause infertility and for women with subfertility the prevalence rate ranges from 25% to 40% (Ozkan 2008). Endometriosis frequently presents with the symptom of pain (Barlow 1993) including dysmenorrhoea (painful periods), dyspareunia (pain during sexual intercourse), and pelvic or abdominal pain.  We invited Edgardo Somigliana, MD-PhD (Dept Clinical Sciences and Community Health, Universit...
Source: Cochrane News and Events - March 22, 2019 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Study links perimenopause to accelerated fat mass gains, lean mass losses
FINDINGSThe menopause transition, also known as perimenopause, is the time in a woman ’s life when hormonal changes lead to irregular menstruation, hot flashes and other symptoms leading up to menopause, when menstruation stops altogether. The researchers found that women undergoing perimenopause lost lean body mass and more than doubled their fat mass. The women’s lean and fat mass remained stable after the transition to menopause. The researchers also noted ethnic/racial differences in the impact of menopause on body composition.BACKGROUNDThe relationship between menopause and changes in body composition...
Source: UCLA Newsroom: Health Sciences - March 20, 2019 Category: Universities & Medical Training Source Type: news

Hormonal Therapy for Prostate Cancer Might Raise Depression Risk
Title: Hormonal Therapy for Prostate Cancer Might Raise Depression RiskCategory: Health NewsCreated: 3/19/2019 12:00:00 AMLast Editorial Review: 3/20/2019 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - March 20, 2019 Category: Cancer & Oncology Source Type: news

Hormonal Therapy for Prostate Cancer Might Raise Depression Risk
TUESDAY, March 19, 2019 -- Hormonal treatment can help control prostate cancer but may increase a man's risk of depression, a new study by Danish researchers suggests. Male hormones, such as testosterone, are known to fuel the growth of prostate... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 19, 2019 Category: General Medicine Source Type: news

Test Predicts Resistance to Hormonal Therapy in Prostate Cancer
(MedPage Today) -- Validation study confirms assist in decision-making (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 16, 2019 Category: Hematology Source Type: news

Molecular 'Clues' May Predict Breast Cancer Return
If doctors could better predict which patients had a high recurrence risk, those women might want to continue hormone therapy past the standard five years. (Source: WebMD Health)
Source: WebMD Health - March 13, 2019 Category: Consumer Health News Source Type: news